Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Current Ratio Over TimeElevated
Percentile Rank100
3Y CAGR+85.8%
5Y CAGR+68.8%
Year-over-Year Change
Current ratio (current assets / current liabilities)
3Y CAGR
+85.8%/yr
vs +34.0%/yr prior
5Y CAGR
+68.8%/yr
Recent acceleration
Acceleration
+51.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
13.7x
Strong expansion
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 19.96 | +997.7% |
| 2023 | 1.82 | +144.9% |
| 2022 | 0.74 | -76.1% |
| 2021 | 3.11 | +82.1% |
| 2020 | 1.71 | +17.2% |
| 2019 | 1.46 | +74.2% |
| 2018 | 0.84 | -13.2% |
| 2017 | 0.96 | -26.6% |
| 2016 | 1.31 | -64.5% |
| 2015 | 3.70 | - |